Culturally Informed Care Coordination for Kidney Disease
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Culturally informed care coordination intervention for kidney disease?
Research shows that culturally tailored interventions, like using community health workers and patient navigators, can improve health outcomes for ethnic minorities with chronic kidney disease by addressing social challenges and enhancing patient education. These approaches have been effective in other conditions, such as cancer care, and show promise in improving care for kidney disease patients from diverse backgrounds.12345
Is culturally informed care coordination for kidney disease safe for humans?
How does the culturally informed care coordination treatment for kidney disease differ from other treatments?
This treatment is unique because it focuses on culturally tailored interventions, using community-based patient navigators and community health workers to address social challenges and improve outcomes for ethnic minorities with kidney disease. Unlike standard treatments, it emphasizes cultural and linguistic concordance to bridge gaps between patients and the healthcare system.12345
What is the purpose of this trial?
Native Hawaiians (NH) are 9.5 times more likely to be on dialysis or need a kidney transplant compared to Whites. They have the highest end-stage kidney disease (ESKD) incidence rates in the nation, begin dialysis at younger ages (30-50 years), and one of the most under-studied racial/ethnic groups in chronic kidney disease (CKD) research. This project's outcome is to improve kidney disease follow-up among early stage NHs at high risk by aligning health equity with a culturally appropriate care coordination systems model.
Research Team
Merle R Kataoka-Yahiro, DrPH., MPH., MS.
Principal Investigator
University of Hawaii at Manoa
Eligibility Criteria
This trial is for Native Hawaiians who are at high risk of kidney disease, particularly those in the early stages. It aims to improve follow-up care by using a culturally appropriate care coordination model.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Formative Evaluation
Conduct a formative evaluation on the barriers and facilitators of care coordination and follow-up for eGFR and UACR among participants and staff.
Intervention Evaluation
Evaluate the acceptability and feasibility of a culturally-informed care coordination intervention at selected PCP sites.
Follow-up
Participants are monitored for the effectiveness of the intervention and re-screening rates.
Treatment Details
Interventions
- Culturally informed care coordination intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Hawaii
Lead Sponsor
National Kidney Foundation
Collaborator
National Kidney Foundation, United States
Collaborator
National Kidney Foundation
Collaborator